-
EP1515989
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1515989
| EP1515989 - IMMUNOGENIC CONJUGATES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.06.2007 Database last updated on 24.01.2025 | Most recent event Tooltip | 22.06.2007 | Application deemed to be withdrawn | published on 25.07.2007 [2007/30] | Applicant(s) | For all designated states Protherics PLC The Health Business and Technical Park, Runcom Cheshire WA7 4QF / GB | [2005/12] | Inventor(s) | 01 /
GLOVER, James The Health Business & Technical Park Runcom Cheshire WA7 4QF / GB | 02 /
DOWNHAM, Matthew The Health Business&TechnicalPark Runcom Cheshire WA7 4QF / GB | 03 /
ROSUL, Ajaz The Health Business and Technical Park Runcom Cheshire WA7 4QF / GB | 04 /
SPENCER, Deborah The Health Business&TechnicalPark Runcom Cheshire WA7 4QF / GB | 05 /
HARGRAVE, Iain The Health Business & Technical Park Runcom Cheshire WA7 4QF / GB | [2005/12] | Representative(s) | Cockbain, Julian Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB | [N/P] |
| Former [2005/12] | Cockbain, Julian, Dr. Frank B. Dehn & Co., European Patent Attorneys, 179 Queen Victoria Street London EC4V 4EL / GB | Application number, filing date | 03740745.9 | 17.06.2003 | [2005/12] | WO2003GB02596 | Priority number, date | GB20020013878 | 17.06.2002 Original published format: GB 0213878 | [2005/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03106487 | Date: | 24.12.2003 | Language: | EN | [2003/52] | Type: | A1 Application with search report | No.: | EP1515989 | Date: | 23.03.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.12.2003 takes the place of the publication of the European patent application. | [2005/12] | Search report(s) | International search report - published on: | EP | 24.12.2003 | Classification | IPC: | C07K14/475, C07K17/06, C07K19/00, A61K38/18, A61K47/42, C12N15/62 | [2005/12] | CPC: |
C07K14/52 (EP,US);
A61K38/1866 (EP,US);
A61K47/6415 (EP,US);
A61K47/646 (EP,US);
A61P35/00 (EP);
A61P35/04 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/12] | Extension states | AL | 12.01.2005 | LT | 12.01.2005 | LV | 12.01.2005 | MK | 12.01.2005 | Title | German: | IMMUNOGENE KONJUGATE | [2005/12] | English: | IMMUNOGENIC CONJUGATES | [2005/12] | French: | CONJUGUES IMMUNOGENES | [2005/12] | Entry into regional phase | 12.01.2005 | National basic fee paid | 12.01.2005 | Designation fee(s) paid | 12.01.2005 | Examination fee paid | Examination procedure | 16.01.2004 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 12.01.2005 | Examination requested [2005/12] | 18.07.2006 | Despatch of a communication from the examining division (Time limit: M06) | 29.01.2007 | Application deemed to be withdrawn, date of legal effect [2007/30] | 06.03.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/30] | Fees paid | Renewal fee | 23.06.2005 | Renewal fee patent year 03 | 26.06.2006 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9606641 (PRIZM PHARMA INC [US]) [X] 1-20* the whole document * | Examination | - RAMAKRISHNAN S. ET AL, "Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo", CANCER RESEARCH, (1996), vol. 54, pages 1324 - 1330, XP001247100 | - RAMAKRISHNAN S. ET AL, "Targeting tumor vasculature using VEGF-toxin conjugates", METHODS IN MOLECULAR BIOLOGY, (2001), vol. 166, pages 219 - 234, XP009068888 | - OLSON T. ET AL, "Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate", INTERNATIONAL JOURNAL OF CANCER, (1997), pages 865 - 870 |